UCB — Major Shareholding Notification 2018

Jul 13, 2018

Transparency notification

Brussels (Belgium), 13 July 2018 – 20:00 (CEST) – regulated information

1. Summary of the notification

Pursuant to Article 14 of the law of 2 May 2007 on the disclosure of large shareholdings, UCB SA/NV announces that it has received a transparency notification dated 9 July 2018 from BlackRock, Inc. (having its registered office at 55 East 52nd Street, New York, NY, 10055, U.S.A.).

BlackRock, Inc. has notified that, following an acquisition of UCB shares with voting rights and equivalent financial instruments by its affiliates, its shareholding in UCB SA has increased and has crossed the 5% threshold on 6 July 2018.

On 6 July 2018, BlackRock, Inc. (taking into account the holding of its affiliates) owned 8 982 056 UCB shares with voting rights (versus 8 780 237 shares in its previous notification dated 3 July 2018), representing 4.62% of the total number of shares issued by the company (194 505 658) (versus 4.51% in the notification dated 3 July 2018) as well as 803 011 equivalent financial instruments (versus 779 207 in its previous notification dated 3 July 2018) representing 0.41% of the total number of shares issued by the company (versus 0.40% in the notification dated 3 July 2018).

2. Content of the notification

The transparency notification dated 9 July 2018 includes the following information:

• Reason for the notification: Acquisition or disposal of voting securities or voting rights.
• Notification by: A parent undertaking or a controlling person.
• Person subject to the notification requirement:

Name	Address (for legal entities)
BlackRock, Inc.	55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock (Netherlands) B.V.	Rembrandt Tower, 17th floor, Amstelplein, Amsterdam, Netherlands
BlackRock (Singapore) Limited	20 Anson Road #18-01, Singapore, 79912, Singapore
BlackRock Advisors (UK) Limited	12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Advisors, LLC	100 Bellevue Parkway, Wilmington, DE, 19809, U.S.A.
BlackRock Asset Management Canada Limited	161 Bay Street, Suite 2500, Toronto, Ontario, M5J 2S1, Canada
BlackRock Asset Management Deutschland AG	Max-Joseph-Straße 6, Munich, 80333, Germany
BlackRock Asset Management North Asia Limited	15/F, 16/F, 17/F Citibank Tower & 17/F ICBC Tower, 3 Garden Road, Central, Hong Kong
BlackRock Financial Management, Inc.	55 East 52nd Street, New York, NY, 10055, U.S.A.
BlackRock Fund Advisors	400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock Institutional Trust Company, National Association	400 Howard Street, San Francisco, CA, 94105, U.S.A.
BlackRock International Limited	Exchange Place One, 1 Semple Street, Edinburgh, EH3 8BL, U.K.
BlackRock Investment Management (Australia) Limited	Level 37, Chifley Tower, 2 Chifley Square, Sydney NSW 2000 Australia
BlackRock Investment Management (UK) Limited	12 Throgmorton Avenue, London, EC2N 2DL, U.K.
BlackRock Investment Management, LLC	1 University Square Drive, Princeton, NJ, 8540, U.S.A.
BlackRock Japan Co., Ltd.	1-8-3 Marunouchi Chiyoda-ku, Trust Tower Main, Tokyo, 100-8217, Japan

• Date on which the threshold is crossed: 6 July 2018.
• Threshold crossed (in %): 5%
• Denominator: 194 505 658.
• Notified details:

UCB
News

A) Voting rights		Previous notification		After the transaction
		# of voting rights		# of voting rights				% of voting rights
Holders of voting rights					Linked to securities		Not linked to the securities		Linked to securities	Not linked to the securities
BlackRock, Inc.		$\mathbf{0}$			$\mathbf 0$				0.00%
BlackRock (Netherlands) B.V.		20.988			20.988				0,01%
BlackRock (Singapore) Limited		7.282			7.282				0,00%
BlackRock Advisors (UK) Limited		1.281.041			1.344.314				0,69%
BlackRock Advisors, LLC		226.091			229.077				0,12%
BlackRock Asset Management Canada Limited		149.100			148.832				0,08%
BlackRock Asset Management Deutschland AG	252.088				252.530				0,13%
BlackRock Asset Management North Asia Limited		8.693			997				0,00%
BlackRock Financial Management, Inc.		166.219			166.217				0,09%
BlackRock Fund Advisors		2.399.275			2.402.431				1,24%
BlackRock Institutional Trust Company, National Association		3.210.225			3.235.981			1.66%
BlackRock International Limited		25.297			25.297				0,01%
BlackRock Investment Management (Australia) Limited		70.951			67.717				0,03%
BlackRock Investment Management (UK) Limited		400.217			323.251				0,17%
BlackRock Investment Management, LLC		340.477			295.986				0,15%
BlackRock Japan Co., Ltd.		222.293			461.156				0,24%
Subtotal		8.780.237		8.982.056					4,62%
	TOTAL 8.982.056		0			4,62%	0,00%
B) Equivalent financial instruments					After the transaction
Holders of equivalent financial instruments		Type of financial instrument		Expiration date	Exercise period or date		# of voting rights that may be acquired if the instrument is exercised		% of voting rights	Settlement
BlackRock Advisors (UK) Limited		Securities Lent					55.043		0,03%	physical
BlackRock Investment Management (UK) Limited		Securities Lent					25.437		0,01%	physical
BlackRock Advisors (UK) Limited		Contract for Difference					4.807	0,00%		cash
BlackRock Advisors, LLC		Contract for Difference					13.522	0,01%		cash
BlackRock Institutional Trust Company, National Association		Contract for Difference					351.322	0,18%		cash
BlackRock International Limited		Contract for Difference					9.602		0,00%	cash
BlackRock Investment Management (UK) Limited		Contract for Difference					216.553		0,11%	cash
BlackRock Investment Management, LLC		Contract for Difference					126.725		0,07%	cash

803.011

$0,41%$

The Inspired by patients.
Driven by science.

TOTAL

TOTAL (A & B)		# of voting rights % of voting rights
	CALCULATE	9.785.067	5,03%

• Chain of controlled undertakings through which the holding is effectively held: Please see the full chain of control in the PDF which is sent separately to this notification.
• Additional information:

The disclosure obligation arose due to total voting rights for BlackRock, Inc. going above 5%.

3. Further information

This press release and the detailed transparency notification are available on UCB SA/NV's website via the following link.

An updated overview of the UCB SA/NV large shareholdings will be available on UCB SA/NV's website via the following link.

Investor Relations

Antje Witte, Investor Relations, UCB T +32 2 559 94 14, antje.witte@ucb.com

Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, isabelle.ghellynck@ucb.com

About UCB

UCB, Brussels, Belgium (www.ucb.com) is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system. With more than 7 500 people in approximately 40 countries, the company generated revenue of € 4.5 billion in 2017. UCB is listed on Euronext Brussels (symbol: UCB). Follow us on Twitter: @UCB_news